Skip to main content
Log in

32/w mit irritativen Miktionsbeschwerden

Vorbereitung auf die Facharztprüfung: Fall 19

32/f with lower urinary tract symptoms

Preparation for the medical specialist examination: part 19

  • Facharzt-Training
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21(2):167–178

    Article  Google Scholar 

  2. Schultz-Lampel D, Goepel M, Haferkamp A (2012) Urodynamik, 3. Aufl. Springer, Berlin Heidelberg

    Book  Google Scholar 

  3. Blok B, Castro-Diaz D, Del Popolo G, Groen J, Hamid R, Karsenty G, Kessler TM (2020) EAU guidelines on neuro-urology

    Google Scholar 

  4. Lian WQ, Li FJ, Huang HX, Zheng YQ, Chen LH (2019) Constipation and risk of urinary incontinence in women: a meta-analysis. Int Urogynecol J Pelvic Floor Dysfunct 30(10):1629–1634. https://doi.org/10.1007/s00192-019-03941-w

    Article  Google Scholar 

  5. Abreu GE, Dourado ER, Alves DN, Araujo MQ, Mendonça NSP, Barroso JU (2018) Functional constipation and overactive bladder in women: a population-based study. Arq Gastroenterol 55(Suppl 1):35–40. https://doi.org/10.1590/s0004-2803.201800000-46

    Article  Google Scholar 

  6. Schafer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van Kerrebroeck P (2002) Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21(3):261–274

    Article  Google Scholar 

  7. Sullivan J, Lewis P, Howell S, Williams T, Shepherd AM, Abrams P (2003) Quality control in urodynamics: a review of urodynamic traces from one centre. BJU Int 91(3):201–207

    Article  CAS  Google Scholar 

  8. Peyronnet B, Mironska E, Chapple C, Cardozo L, Oelke M, Dmochowski R, Amarenco G, Game X, Kirby R, Van Der Aa F, Cornu JN (2019) A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. Eur Urol 75(6):988–1000. https://doi.org/10.1016/j.eururo.2019.02.038

    Article  PubMed  Google Scholar 

  9. Sakakibara R, Panicker J, Fowler CJ, Tateno F, Kishi M, Tsuyusaki Y, Yamanishi T, Uchiyama T, Yamamoto T, Yano M (2014) Is overactive bladder a brain disease? The pathophysiological role of cerebral white matter in the elderly. Int J Urol 21(1):33–38. https://doi.org/10.1111/iju.12288

    Article  PubMed  Google Scholar 

  10. Andersson KE, Boedtkjer DB, Forman A (2017) The link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction. Ther Adv Urol 9(1):11–27. https://doi.org/10.1177/1756287216675778

    Article  CAS  PubMed  Google Scholar 

  11. Greenland JE, Hvistendahl JJ, Andersen H, Jörgensen TM, McMurray G, Cortina-Borja M, Brading AF, Frøkiær J (2000) The effect of bladder outlet obstruction on tissue oxygen tension and blood flow in the pig bladder. BJU Int 85(9):1109–1114. https://doi.org/10.1046/j.1464-410x.2000.00611.x

    Article  CAS  PubMed  Google Scholar 

  12. Ponholzer A, Temml C, Wehrberger C, Marszalek M, Madersbacher S (2006) The association between vascular risk factors and lower urinary tract symptoms in both sexes. Eur Urol 50(3):581–586. https://doi.org/10.1016/j.eururo.2006.01.031

    Article  PubMed  Google Scholar 

  13. Chapple CR, Khullar V, Gabriel Z, Muston D, Bitoun CE, Weinstein D (2008) The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 54(3):543–562. https://doi.org/10.1016/j.eururo.2008.06.047

    Article  CAS  PubMed  Google Scholar 

  14. Chapple CR, Cardozo L, Nitti VW, Siddiqui E, Michel MC (2014) Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn 33(1):17–30. https://doi.org/10.1002/nau.22505

    Article  CAS  PubMed  Google Scholar 

  15. Tyagi P, Tyagi V, Chancellor M (2011) Mirabegron: a safety review. Expert Opin Drug Saf 10(2):287–294. https://doi.org/10.1517/14740338.2011.542146

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tanja Hüsch FEBU.

Ethics declarations

Interessenkonflikt

T. Hüsch deklariert Angestelltenverhältnis bei Promedon GmbH außerhalb dieser Arbeit. A. Reitz, L. Schneidewind und J. Kranz geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. Für Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, über die Patienten zu identifizieren sind, liegt von ihnen und/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.

The supplement containing this article is not sponsored by industry.

Additional information

Redaktion

U.H. Necknig, Garmisch-Partenkirchen

M.S. Michel, Mannheim

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hüsch, T., Reitz, A., Schneidewind, L. et al. 32/w mit irritativen Miktionsbeschwerden. Urologe 61 (Suppl 2), 56–62 (2022). https://doi.org/10.1007/s00120-021-01655-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-021-01655-w

Schlüsselwörter

Navigation